ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664401 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664401; 2) Community: the network communities that were significantly associated with the response to NSC 664401; 3) Molecule: the relationships between components within communities and NSC 664401; 4) MDR: the compounds that were significantly associated with the NSC 664401.

NSC Compound Enrichment Correlation
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.0119653763676521 0.24585946
NSC 674919 Furan-3(2H)-one, 2-[2-(4-bromophenyl)-2-oxoethylidene]- 5-(2,4-dimethylphenyl)- 0.0119653763676521 0.049039518
NSC 679017 Null 0.0119653763676521 0.32463061
NSC 679021 Null 0.0119653763676521 0.32415528
NSC 686556 Benzo[g]quinoline-5,10-dione, 4-[2-(dimethylamino) ethenyl]- 0.0119653763676521 0.43655716
NSC 174121 Methotrexate Derivative 0.0119653763676522 0.29776159
NSC 65537 Null 0.0119653763676522 0.41397688
NSC 107043 Null 0.0133986477026051 0.23472504
NSC 120925 Null 0.0133986477026051 0.58077879
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0133986477026051 0.36724797
Total:66  Current:19    [First] [Prev] [Next] [Last]